The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
POLEM: Avelumab plus fluoropyrimidine-based chemotherapy as adjuvant treatment for stage III dMMR or POLE exonuclease domain mutant colon cancer—A phase III randomized study.
 
David Lau
Research Funding - Merck
Travel, Accommodations, Expenses - Roche
 
David Cunningham
Research Funding - 4SC (Inst); Amgen (Inst); AstraZeneca (Inst); Bayer (Inst); Celgene (Inst); Clovis Oncology (Inst); Janssen (Inst); Lilly (Inst); MedImmune (Inst); Merck (Inst); Merrimack (Inst); Sanofi (Inst)
 
Angela Gillbanks
No Relationships to Disclose
 
Richard Crux
No Relationships to Disclose
 
Rachel Powell
No Relationships to Disclose
 
Eleftheria Kalaitzaki
No Relationships to Disclose
 
Nicola E. Annels
No Relationships to Disclose
 
Francesco Sclafani
No Relationships to Disclose
 
Marco Gerlinger
Research Funding - Bristol-Myers Squibb (Inst); Merck (Inst)
 
Ian Chau
Honoraria - Lilly
Consulting or Advisory Role - AstraZeneca; Bayer; Bristol-Myers Squibb; Lilly; Merck Serono; MSD Oncology; Oncologie; Roche/Genentech
Research Funding - Janssen-Cilag (Inst); Lilly (Inst); Merck Serono (Inst); Sanofi (Inst)
Travel, Accommodations, Expenses - Bristol-Myers Squibb; Lilly; Merck Serono; MSD
 
Ian Tomlinson
No Relationships to Disclose
 
Naureen Starling
Research Funding - AstraZeneca; Bristol-Myers Squibb; Lilly; Merck
 
Hardev S. Pandha
No Relationships to Disclose
 
David N. Church
No Relationships to Disclose
 
Tony Dhillon
Research Funding - Merck
Travel, Accommodations, Expenses - Bayer; MSD